ID   CSPG5_RAT               Reviewed;         571 AA.
AC   Q9ERQ6; Q62831;
DT   27-SEP-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   27-MAR-2024, entry version 132.
DE   RecName: Full=Chondroitin sulfate proteoglycan 5;
DE   AltName: Full=Acidic leucine-rich EGF-like domain-containing brain protein;
DE   AltName: Full=Neuroglycan C;
DE   Flags: Precursor;
GN   Name=Cspg5; Synonyms=Caleb, Ngc;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), PROTEIN SEQUENCE OF 31-45; 232-238
RP   AND 337-356, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, AND GLYCOSYLATION.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=7592931; DOI=10.1074/jbc.270.45.26876;
RA   Watanabe E., Maeda N., Matsui F., Kushima Y., Noda M., Oohira A.;
RT   "Neuroglycan C, a novel membrane-spanning chondroitin sulfate proteoglycan
RT   that is restricted to the brain.";
RL   J. Biol. Chem. 270:26876-26882(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=11069908; DOI=10.1074/jbc.m007234200;
RA   Schumacher S., Jung M., Noerenberg U., Dorner A., Chiquet-Ehrismann R.,
RA   Stuermer C.A.O., Rathjen F.G.;
RT   "CALEB binds via its acidic stretch to the fibrinogen-like domain of
RT   tenascin-C or tenascin-R and its expression is dynamically regulated after
RT   optic nerve lesion.";
RL   J. Biol. Chem. 276:7337-7345(2001).
RN   [3]
RP   TISSUE SPECIFICITY, AND GLYCOSYLATION.
RC   TISSUE=Brain;
RX   PubMed=9950058; DOI=10.1016/s0168-0102(98)00098-4;
RA   Yasuda Y., Tokita Y., Aono S., Matsui F., Ono T., Sonta S., Watanabe E.,
RA   Nakanishi Y., Oohira A.;
RT   "Cloning and chromosomal mapping of the human gene of neuroglycan C (NGC),
RT   a neural transmembrane chondroitin sulfate proteoglycan with an EGF
RT   module.";
RL   Neurosci. Res. 32:313-322(1998).
RN   [4]
RP   DEVELOPMENTAL STAGE, AND TISSUE SPECIFICITY.
RX   PubMed=11095636;
RA   Inatani M., Tanihara H., Oohira A., Otori Y., Nishida A., Honjo M.,
RA   Kido N., Honda Y.;
RT   "Neuroglycan C, a neural tissue-specific transmembrane chondroitin sulfate
RT   proteoglycan, in retinal neural network formation.";
RL   Invest. Ophthalmol. Vis. Sci. 41:4338-4346(2000).
RN   [5]
RP   PHOSPHORYLATION, AND SUBCELLULAR LOCATION.
RX   PubMed=11929867; DOI=10.1074/jbc.m200909200;
RA   Yamauchi S., Tokita Y., Aono S., Matsui F., Shuo T., Ito H., Kato K.,
RA   Kasahara K., Oohira A.;
RT   "Phosphorylation of neuroglycan C, a brain-specific transmembrane
RT   chondroitin sulfate proteoglycan, and its localization in the lipid
RT   rafts.";
RL   J. Biol. Chem. 277:20583-20590(2002).
RN   [6]
RP   INDUCTION.
RX   PubMed=12358776; DOI=10.1046/j.1471-4159.2002.01083.x;
RA   Toda S., McGinty J.F., Kalivas P.W.;
RT   "Repeated cocaine administration alters the expression of genes in
RT   corticolimbic circuitry after a 3-week withdrawal: a DNA macroarray
RT   study.";
RL   J. Neurochem. 82:1290-1299(2002).
RN   [7]
RP   INTERACTION WITH MDK.
RX   PubMed=16901907; DOI=10.1074/jbc.m602228200;
RA   Ichihara-Tanaka K., Oohira A., Rumsby M., Muramatsu T.;
RT   "Neuroglycan C is a novel midkine receptor involved in process elongation
RT   of oligodendroglial precursor-like cells.";
RL   J. Biol. Chem. 281:30857-30864(2006).
CC   -!- FUNCTION: May function as a growth and differentiation factor involved
CC       in neuritogenesis. May induce ERBB3 activation.
CC   -!- SUBUNIT: Interacts with ERBB3 and GOPC. Binds TNR and probably TNC (By
CC       similarity). Interacts with MDK; this interaction is independent of the
CC       presence of chondroitin sulfate chains and promotes elongation of
CC       oligodendroglial precursor-like cells (PubMed:16901907). {ECO:0000250,
CC       ECO:0000269|PubMed:16901907}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11929867};
CC       Single-pass type I membrane protein {ECO:0000269|PubMed:11929867}.
CC       Synaptic cell membrane {ECO:0000250|UniProtKB:Q71M36}; Single-pass type
CC       I membrane protein {ECO:0000250|UniProtKB:Q71M36}. Endoplasmic
CC       reticulum membrane {ECO:0000250|UniProtKB:Q71M36}; Single-pass type I
CC       membrane protein {ECO:0000250|UniProtKB:Q71M36}. Golgi apparatus
CC       membrane {ECO:0000250|UniProtKB:Q71M36}; Single-pass type I membrane
CC       protein {ECO:0000250|UniProtKB:Q71M36}. Cell surface
CC       {ECO:0000250|UniProtKB:Q71M36}. Secreted
CC       {ECO:0000250|UniProtKB:O95196}. Note=In neurons, localizes to synaptic
CC       junctions. Also detected in the endoplasmic reticulum and the Golgi (By
CC       similarity). Partially enriched in lipid rafts (PubMed:11929867).
CC       {ECO:0000250|UniProtKB:Q71M36, ECO:0000269|PubMed:11929867}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9ERQ6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9ERQ6-2; Sequence=VSP_015765;
CC   -!- TISSUE SPECIFICITY: Expressed in cerebral cortex and cerebellum.
CC       Expressed in retina (at protein level). {ECO:0000269|PubMed:11069908,
CC       ECO:0000269|PubMed:11095636, ECO:0000269|PubMed:7592931,
CC       ECO:0000269|PubMed:9950058}.
CC   -!- DEVELOPMENTAL STAGE: Expression starts at 16 dpc in the cerebral cortex
CC       and increases to reach a maximum 20 days after birth. Then it decreases
CC       till adulthood to be expressed half of the peak level. In the retina,
CC       expression reaches a maximum at postnatal day 14 (P14). It starts
CC       weakly at 16 dpc in the retinal pigment epithelium (RPE). At P0 it is
CC       detected in nerve fiber layer (NFL), ganglion cell layer (GCL), inner
CC       plexiform layer (IPL) and RPE. At P7, it becomes intense in the NFL and
CC       IPL. At P14, expression becomes intense in the area of outer segments
CC       (OS) of the photoreceptor cells as well as in RPE, whereas in the inner
CC       layers it becomes gradually fainter. From P21 to P42, it decreases in
CC       inner retinal layers. OS and RPE still express, whereas expression in
CC       the NFL and IPL decreases (at protein level).
CC       {ECO:0000269|PubMed:11095636, ECO:0000269|PubMed:7592931}.
CC   -!- INDUCTION: Up-regulated in nucleus accumbens shell by cocaine
CC       administration. {ECO:0000269|PubMed:12358776}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:7592931,
CC       ECO:0000269|PubMed:9950058}.
CC   -!- PTM: O-glycosylated; contains chondroitin sulfate glycans. Part-time
CC       proteoglycan, expressed in part as a proteoglycan exhibiting
CC       chondroitin sulfate glycans and in part as a non-proteoglycan form. The
CC       relative amount of both forms depends on tissues and tissue maturation
CC       (By similarity). {ECO:0000250|UniProtKB:Q71M36}.
CC   -!- PTM: Phosphorylated; in intracellular and extracellular parts.
CC       {ECO:0000269|PubMed:11929867}.
CC   -!- MISCELLANEOUS: Different forms of various molecular weight have been
CC       observed. Such forms are possibly due to different levels of
CC       glycosylation, phosphorylation and/or protein cleavage (By similarity).
CC       {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U33553; AAC98537.1; -; mRNA.
DR   EMBL; AF292102; AAG29500.1; -; mRNA.
DR   PIR; I55454; I55454.
DR   RefSeq; NP_062157.1; NM_019284.1. [Q9ERQ6-2]
DR   RefSeq; NP_598413.1; NM_133652.1. [Q9ERQ6-1]
DR   AlphaFoldDB; Q9ERQ6; -.
DR   BioGRID; 248393; 1.
DR   STRING; 10116.ENSRNOP00000028278; -.
DR   GlyCosmos; Q9ERQ6; 15 sites, No reported glycans.
DR   GlyGen; Q9ERQ6; 16 sites.
DR   iPTMnet; Q9ERQ6; -.
DR   PhosphoSitePlus; Q9ERQ6; -.
DR   PaxDb; 10116-ENSRNOP00000028278; -.
DR   Ensembl; ENSRNOT00000028278.8; ENSRNOP00000028278.8; ENSRNOG00000020833.8. [Q9ERQ6-1]
DR   Ensembl; ENSRNOT00055012504; ENSRNOP00055009923; ENSRNOG00055007502. [Q9ERQ6-1]
DR   Ensembl; ENSRNOT00060050019; ENSRNOP00060041689; ENSRNOG00060028775. [Q9ERQ6-1]
DR   Ensembl; ENSRNOT00065011598; ENSRNOP00065008454; ENSRNOG00065007430. [Q9ERQ6-1]
DR   GeneID; 50568; -.
DR   KEGG; rno:50568; -.
DR   UCSC; RGD:2431; rat. [Q9ERQ6-1]
DR   AGR; RGD:2431; -.
DR   CTD; 10675; -.
DR   RGD; 2431; Cspg5.
DR   eggNOG; ENOG502QXSB; Eukaryota.
DR   GeneTree; ENSGT00440000034270; -.
DR   InParanoid; Q9ERQ6; -.
DR   OMA; WEPHAND; -.
DR   OrthoDB; 5322387at2759; -.
DR   PhylomeDB; Q9ERQ6; -.
DR   Reactome; R-RNO-1971475; A tetrasaccharide linker sequence is required for GAG synthesis.
DR   Reactome; R-RNO-2022870; Chondroitin sulfate biosynthesis.
DR   Reactome; R-RNO-2022923; Dermatan sulfate biosynthesis.
DR   Reactome; R-RNO-2024101; CS/DS degradation.
DR   PRO; PR:Q9ERQ6; -.
DR   Proteomes; UP000002494; Chromosome 8.
DR   GO; GO:0009986; C:cell surface; IEA:UniProtKB-SubCell.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0098982; C:GABA-ergic synapse; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030660; C:Golgi-associated vesicle membrane; ISS:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; ISO:RGD.
DR   GO; GO:0045202; C:synapse; IBA:GO_Central.
DR   GO; GO:0031103; P:axon regeneration; IEP:RGD.
DR   GO; GO:0048858; P:cell projection morphogenesis; IBA:GO_Central.
DR   GO; GO:0007010; P:cytoskeleton organization; IMP:UniProtKB.
DR   GO; GO:0106091; P:glial cell projection elongation; IDA:UniProtKB.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; ISO:RGD.
DR   GO; GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; IMP:UniProtKB.
DR   GO; GO:2000300; P:regulation of synaptic vesicle exocytosis; ISO:RGD.
DR   InterPro; IPR042382; CSPG5.
DR   InterPro; IPR010555; CSPG5_S_attach_dom.
DR   InterPro; IPR009505; Neural_ProG_Cyt.
DR   PANTHER; PTHR15381:SF1; CHONDROITIN SULFATE PROTEOGLYCAN 5; 1.
DR   PANTHER; PTHR15381; CHONDROITIN SULFATE PROTEOGLYCAN 5 -RELATED; 1.
DR   Pfam; PF06566; Chon_Sulph_att; 1.
DR   Pfam; PF06567; Neural_ProG_Cyt; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Developmental protein;
KW   Differentiation; Direct protein sequencing; Disulfide bond;
KW   EGF-like domain; Endoplasmic reticulum; Glycoprotein; Golgi apparatus;
KW   Growth regulation; Membrane; Neurogenesis; Phosphoprotein; Proteoglycan;
KW   Reference proteome; Secreted; Signal; Synapse; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..30
FT                   /evidence="ECO:0000269|PubMed:7592931"
FT   CHAIN           31..571
FT                   /note="Chondroitin sulfate proteoglycan 5"
FT                   /id="PRO_0000042153"
FT   TOPO_DOM        31..428
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        429..449
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        450..571
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          376..418
FT                   /note="EGF-like"
FT   REGION          57..91
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          137..169
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          186..254
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          270..306
FT                   /note="Interaction with TNC and TNR"
FT                   /evidence="ECO:0000250"
FT   REGION          279..357
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          447..465
FT                   /note="Interaction with GOPC"
FT                   /evidence="ECO:0000250"
FT   REGION          538..563
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        279..299
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         472
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q71M36"
FT   MOD_RES         480
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q71M36"
FT   MOD_RES         488
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q71M36"
FT   MOD_RES         548
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q71M36"
FT   CARBOHYD        38
FT                   /note="O-linked (Xyl...) (chondroitin sulfate) serine"
FT                   /evidence="ECO:0000250|UniProtKB:O95196"
FT   CARBOHYD        57
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        76
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        123
FT                   /note="O-linked (Xyl...) (chondroitin sulfate) serine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        132
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        143
FT                   /note="O-linked (GalNAc...) serine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        144
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        153
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        156
FT                   /note="O-linked (GalNAc...) serine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        160
FT                   /note="O-linked (GalNAc...) serine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        162
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        198
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        240
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        318
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        322
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        372
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        379..392
FT                   /evidence="ECO:0000250"
FT   DISULFID        386..402
FT                   /evidence="ECO:0000250"
FT   DISULFID        404..417
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         492..518
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:7592931"
FT                   /id="VSP_015765"
FT   CONFLICT        565
FT                   /note="C -> F (in Ref. 1; AAC98537)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   571 AA;  60959 MW;  CF42A0115F0CD11E CRC64;
     MGRAGGGGPG WGPPPVLLLL GVTLVLTAGA VPAREAGSAI EAEELVRSGL AWESRANDTR
     EEAGLPAAGE DETSWTERGS ELAAVGPGVG PEETLEASAA VTGTAWLEAD GTGLGGVTAE
     AGSGDAQTLP ATLQAPDEAL GSSTMPPAIP EATEASGPPS PTLRDKPSLV PELPKEIPLE
     VWLNLGGSTP DPQRPEPTFP LQGTLETQPA SDIIDIDYFE GLDSEGRGTD MGRFPGSPGT
     SENHPDTEGE TPSWSLLDLY DDFTPFDESD FYPTTSFYDD LEEEEEEEED KDAVGGGDLE
     DESDLLLPSQ KPGVGPGTGQ PTSRWHAVPP QHTLGMVPGG SISLRPRPGD PGKDLATSEN
     GTECRVGFVR HNGSCRSVCD LFPSYCHNGG QCYLVENIGA FCRCNTQDYI WHKGMRCESI
     ITDFQVMCVA VGSAALVLLL LFMMTVFFAK KLYLLKTENT KLRRTNKFRT PSELHNDNFS
     LSTIAEGSHP NVRKLCDTPC VSSPHARALA HCDNIVCQDD PSAPHKIQEA LKSRLKEEES
     FNIQNSMSPK LEGGKGDQDD LEVNCLQNNL T
//
